Volume 93, issue 10, Octobre 2006

Synthèse

HER-2/neu positive breast cancer: how to prescribe adjuvant trastuzumab (Herceptin ^®)? (p.991-9)
Yazid Belkacémi, Joseph Gligorov, Louis Mauriac, David Azria

Risk factors for developing upper limb lymphedema after breast cancer treatment (p.1001-6)
Maria Arrault, Stéphane Vignes

Communiqué

Bulletin de synthèse de veille 2005 Recommandations pour la pratique clinique Prise en charge thérapeutique du cancer de la prostate non métastatique (p.1007-15)
M. Soulié, P. Beuzeboc, P. Richaud, A. Villers, D. Kassab-Chahmi, A. Bataillard

Electronic Journal of Oncology

Epirubicin-based chemotherapy as adjuvant treatment for poor prognosis, node-negative breast cancer: 10-year follow-up results of the French Adjuvant Study Group 03 trial (p.10109-14)
Michel Héry, Jacques Bonneterre, Henri Roché, Elisabeth Luporsi, Pierre Kerbrat, Moïse Namer, Pierre Fumoleau, Alain Monnier, Pierre Fargeot

Article original

Role of [ ¹⁸F]-FDG PET-CT in the management of the head and neck cancers (p.1017-25)
Nicolas Fakhry, Marie Barberet, David Lussato, Serge Cammilleri, Olivier Mundler, Antoine Giovanni, Michel Zanaret

The cost of intensity modulated radiation therapy in head and neck cancers: results of the 2002 STIC study (p.1026-32)
M Julia Bonastre, Eric Noël, René-Jean Bensadoun, Olivier Chapet, Véronique Favrel, Jean-Bernard Dubois, Norbert Ailleres, Philippe Giraud, Dimitri Lefkopoulos, Serge Marcié, Philippe Lagarde, Miriam Gardner, Michel Rives, Hugues Mailleux, Jean Bourhis, Jean-Pierre Gérard, Gérard de Pouvourville

Impact on the quality of pathology reports in the R2c cancer network: analysis of 4521 pathology reports of primary breast tumors (p.1033-8)
Valérie-Jeanne Bardou, Brigitte Puig, Jocelyne Jacquemier, Marie-Hélène Giovannini

Organisational diagnosis of a home care-coordinating unit in oncology: which choices for the comprehensive cancer center of Lyon? (p.1039-46)
Gisèle Chvetzoff, Roland Chvetzoff, Yves Devaux, A Teil, J Chalencon, L Lancry, V Kante, C Poncelas, P Sontag, C Tretiakoff, T Philip

Appropriate cytotoxic drug usages in solid tumors: conformity to official labelling and level of scientific evidence (p.1047-54)
Ludwig Grangeasse, Bruno Coudert, Xavier Pivot, Pierre Fumoleau, Alain Depierre, Bruno Chauffert, Sylvette Huichard, Marie-Christine Woronoff-Lemsi, Patrick Arveux, Samuel Limat

Bio-impedance analysis: screening of malnutrition in a group of Tunisian with cancer patients (p.1055-61)
Leila Trabelsi Alouane, Abdelmoncef Bedioui, Khaled Rahal

Du côté des cancérôpoles et de l’INCa

Activity reports for the year 2005 of tumour banks fi nanced as part of the national cancer plan (p.1062-70)

Brèves

Devenir des patientes ayant bénéficié du prélèvement du ganglion sentinelle pour un carcinome épidermoïde vulvaire après un suivi moyen de 4 ans (p.981-2)
Xavier Carcopino, Max Buttarelli, Emmanuelle Charaffe-Jauffret, Gilles Houvenaeghel, Isabelle Rossi, Agnès Tallet
Open Access

Les antigènes tumoraux MAGE-A ciblent p53 (p.982)
Jean Bénard
Open Access

Point sur

PEA3 family of transcription factors and the regulation of oncogenesis (p.985-9)
Yvan de Launoit, Jean-Luc Baert, Anne Chotteau-Lelievre, Didier Monte, Laurent Coutte, Sébastien Mauen, Virginie Firlej, Cindy Degerny, Kathye Verreman